The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.
 
Dulce M. Barrios M.S
No Relationships to Disclose
 
Diana G. Wang
No Relationships to Disclose
 
Victoria Susana Blinder
Consulting or Advisory Role - Anthem Foundation; Pfizer
 
Jacqueline Bromberg
No Relationships to Disclose
 
Pamela Drullinsky
Research Funding - Novartis (Inst); Roche (Inst)
 
Samuel Aaron Funt
Stock and Other Ownership Interests - Allogene Therapeutics; Hubble (I); Kite, a Gilead company; Kronos Bio (I); Neogene Therapeutics (I); Second Science; Urogen pharma (I); Vida Ventures (I)
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst)
Research Funding - AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Komal L. Jhaveri
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bristol-Myers Squibb; Genentech; Intellisphere; Jounce therapeutics; Lilly; Novartis; Pfizer; Spectrum Pharmaceuticals; Synthon; Taiho Pharmaceutical
Research Funding - ADC Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genentech (Inst); Immunomedics (Inst); Lilly (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Intellisphere; Jounce Therapeutics; Pfizer; Taiho Pharmaceutical
 
Diana Lake
No Relationships to Disclose
 
Tomas Lyons
No Relationships to Disclose
 
Shanu Modi
Honoraria - GlaxoSmithKline; Novartis; Puma Biotechnology
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Macrogenics
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Genentech; Seagen
Research Funding - Daiichi Sankyo; Novartis; Roche/Genentech; Seagen; Synta
Travel, Accommodations, Expenses - Daiichi Sankyo; Genentech
 
Pedram Razavi
Consulting or Advisory Role - AstraZeneca; Foundation Medicine; Novartis
Research Funding - GRAIL (Inst); Illumina (Inst)
Travel, Accommodations, Expenses - Epic Sciences; Guardant Health
 
Michelle Sidel
Employment - Novartis
 
Tiffany A. Traina
Consulting or Advisory Role - Aduro Biotech; Advaxis; AstraZeneca; Athenex; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Genentech/Roche; Genomic Health; Halozyme; Innocrin Pharma; ION Pharma; Merck; Pfizer; Puma Biotechnology; Samsung; Seagen
Speakers' Bureau - Roche/Genentech
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Carrick Pharm (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Innocrin Pharma (Inst); Novartis (Inst); Pfizer (Inst)
 
Linda T. Vahdat
Honoraria - Athenex; Osmol Therapeutics; polyphor; R-Pharm; Seagen
Consulting or Advisory Role - Berg Pharma
Speakers' Bureau - Eisai
Research Funding - Immunomedics (Inst); Polyphor (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)
 
Mario E. Lacouture
Honoraria - ADC Therapeutics; Amgen; Apricity Health; AstraZeneca; azitra; azitra; Deciphera; Galderma; Genentech; Janssen; Johnson & Johnson; Kyowa Hakko Kirin; Loxo; Menlo Therapeutics; NCODA; Novartis; Novocure; OnQuality Pharmaceuticals; QED Therapeutics; Roche/Genentech; Seattle Genetics/Astellas; Teva; Teva
Consulting or Advisory Role - Abbvie; Adgero Biopharmaceuticals; Adjucare; Allergan; Amgen; Amryt Pharma; AstraZeneca; Bayer; Biotechspert; Boehringer Ingelheim; Celldex; Debiopharm Group; Dignitana; E.R. Squibb Sons, LLC; EMD Serono; Galderma; Genentech; Helsinn Healthcare; Janssen Research & Development; Johnson & Johnson; Legacy Healthcare Services; Legacy Healthcare Services; LEO Pharma; Lindi Skin; Lutris; Manner SAS; Menlo Therapeutics; Merck; Novartis; Novocure; OncoDerm; OnQuality Pharmaceuticals; OurBrainBank; Parexel; Paxman; Pierre Fabre; Roche; Roche; Roche; Roche; Seagen; Takeda/Millennium; Teva
Research Funding - Lutris; Novocure; Paxman; US Biotest; Veloce Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Deciphera; Kyowa Hakko Kirin; Novocure; Teva
Other Relationship - OncoDerm (I)
(OPTIONAL) Uncompensated Relationships - OncoDerm; OncoDerm